Proof-of-Concept Study of E1224 to Treat Adult Patients With Chagas Disease
Status:
Unknown status
Trial end date:
2013-12-01
Target enrollment:
Participant gender:
Summary
This study will assess the safety and efficacy of E1224, a pro-drug of ravuconazole, in
individuals with chronic indeterminate Chagas disease recruited in research centres in Tarija
and Cochabamba, Bolivia.